These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group. Grovas AC; Boyett JM; Lindsley K; Rosenblum M; Yates AJ; Finlay JL Med Pediatr Oncol; 1999 Aug; 33(2):83-7. PubMed ID: 10398181 [TBL] [Abstract][Full Text] [Related]
26. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. Guruangan S; Dunkel IJ; Goldman S; Garvin JH; Rosenblum M; Boyett JM; Gardner S; Merchant TE; Gollamudi S; Finlay JL J Clin Oncol; 1998 Jul; 16(7):2486-93. PubMed ID: 9667268 [TBL] [Abstract][Full Text] [Related]
27. Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results--Phase I study. Thomas MR; Robinson WA; Glode LM; Dantas ME; Koeppler H; Morton N; Sutherland J Am J Clin Oncol; 1982 Dec; 5(6):611-22. PubMed ID: 6762087 [TBL] [Abstract][Full Text] [Related]
28. Preliminary results of a phase III comparison study of BCNU, hydroxyurea and radiation to BCNU and radiation. Levin VA; Wilson CB; Davis R; Wara W; Pischer TL; Irwin L Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1573-6. PubMed ID: 231594 [No Abstract] [Full Text] [Related]
29. Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemia. Zander AR; Vellekoop L; Spitzer G; Verma DS; Litam J; McCredie KB; Keating M; Hester JP; Dicke KA Cancer Treat Rep; 1981; 65(5-6):377-81. PubMed ID: 7016323 [TBL] [Abstract][Full Text] [Related]
30. High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease. Zulian GB; Selby P; Milan S; Nandi A; Gore M; Forgeson G; Perren TJ; McElwain TJ Br J Cancer; 1989 Apr; 59(4):631-5. PubMed ID: 2653400 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Alessandrino EP; Bernasconi P; Colombo A; Caldera D; Martinelli G; Vitulo P; Malcovati L; Nascimbene C; Varettoni M; Volpini E; Klersy C; Bernasconi C Bone Marrow Transplant; 2000 Feb; 25(3):309-13. PubMed ID: 10673703 [TBL] [Abstract][Full Text] [Related]
37. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Papadakis V; Dunkel IJ; Cramer LD; Kramer E; Papadopoulos E; Goldman S; Packer RJ; Willoughby M; Baker D; Garvin J; Strandjord S; Coccia P; Kaplan AM; Klemperer M; Finlay JL Bone Marrow Transplant; 2000 Jul; 26(2):153-60. PubMed ID: 10918425 [TBL] [Abstract][Full Text] [Related]
38. Fatal veno-occlusive disease of the liver following high-dose 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and autologous bone marrow transplantation. McIntyre RE; Magidson JG; Austin GE; Gale RP Am J Clin Pathol; 1981 Apr; 75(4):614-7. PubMed ID: 7013473 [TBL] [Abstract][Full Text] [Related]
39. High-dose chemotherapy with autologous bone marrow rescue: haematopoietic reconstitution by non-cryopreserved marrow. Köppler H; Pflüger KH; Havemann K Bone Marrow Transplant; 1991; 7 Suppl 2():143. PubMed ID: 1878685 [No Abstract] [Full Text] [Related]
40. High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. Lazarus HM; Crilley P; Ciobanu N; Creger RJ; Fox RM; Shina DC; Bulova SI; Gucalp R; Cooper BW; Topolsky D J Clin Oncol; 1992 Nov; 10(11):1682-9. PubMed ID: 1403051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]